Hemorrhagic death associated with a high titer factor V inhibitor.

作者: Macie C. Coots , Albert F. Muhleman , Helen I. Glueck

DOI: 10.1002/AJH.2830040212

关键词:

摘要: An acquired bleeding diathesis was first noted in a 51-year-old patient 11 days following an exploratory laparotomy. Laboratory studies indicated the cause of to be development circulating anticoagulant which inhibited factor V activity. The inhibitor, immunoglobulin IgG class, separated by use Sephadex G-200 filtration, disc electrophoresis, and isoelectric focusing. Despite vigorous immunosuppressive, antifibrinolytic, replacement therapy, including “prothrombin complex” plasmaphoresis, could not reversed died hemorrhage. Although inhibitors are usually associated with major life-threatening hemorrhage, this case demonstrates that such inhibitor can ominous finding. aminoglycoside antibiotic other patients so reported may one contributing causes inhibitor.

参考文章(32)
T Pintado, HF Taswell, EJ Bowie, Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor. Blood. ,vol. 46, pp. 535- 541 ,(1975) , 10.1182/BLOOD.V46.4.535.535
MURRAY NUSSBAUM, BERNARD S. MORSE, PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES. Blood. ,vol. 23, pp. 669- 678 ,(1964) , 10.1182/BLOOD.V23.5.669.669
JOHN H. FERGUSON, CHARLES L. JOHNSTON, DORIS A. HOWELL, A Circulating Inhibitor (Anti-AcG) Specific for the Labile Factor-V of the Blood-Clotting Mechanism Blood. ,vol. 13, pp. 382- 397 ,(1958) , 10.1182/BLOOD.V13.4.382.382
Walter B. Forman, Walter B. Forman, Markley H. Boyer, Markley H. Boyer, Oscar D. Ratnoff, Oscar D. Ratnoff, An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. Journal of Laboratory and Clinical Medicine. ,vol. 72, pp. 455- 472 ,(1968) , 10.5555/URI:PII:0022214368901686
V. Lopez, R. Pflugshaupt, R. Bütler, A specific inhibitor of human clotting factor V. Acta Haematologica. ,vol. 40, pp. 275- 285 ,(1968) , 10.1159/000208915
E. B. Crowell, Observations on a factor-V inhibitor. British Journal of Haematology. ,vol. 29, pp. 397- 404 ,(1975) , 10.1111/J.1365-2141.1975.TB01837.X
J.A. Bonnin, K. Cheney, B.M. Duncan, D.A. Handley, Observations on coagulation factors VII and X, and a method for the assay of factor X in blood serum. Pathology. ,vol. 1, pp. 273- 282 ,(1969) , 10.3109/00313026909071306
Donald I. Feinstein, Samuel I. Rapaport, William G. McGehee, Mary Jane Patch, Factor V anticoagulants: clinical, biochemical, and immunological observations Journal of Clinical Investigation. ,vol. 49, pp. 1578- 1588 ,(1970) , 10.1172/JCI106375
Charles T. Esmon, Craig M. Jackson, The factor V activating enzyme of Russell's viper venom Thrombosis Research. ,vol. 2, pp. 509- 524 ,(1973) , 10.1016/0049-3848(73)90004-2